Kemp Dolliver
Stock Analyst at Brookline Capital
(0.67)
# 4,104
Out of 5,126 analysts
19
Total ratings
38.46%
Success rate
-11.96%
Average return
Main Sectors:
Stocks Rated by Kemp Dolliver
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LSTA Lisata Therapeutics | Downgrades: Hold | n/a | $4.54 | - | 2 | Jan 21, 2026 | |
| RNTX Rein Therapeutics | Downgrades: Hold | n/a | $1.14 | - | 2 | Jan 21, 2026 | |
| VRCA Verrica Pharmaceuticals | Upgrades: Buy | $17 | $6.91 | +146.02% | 3 | Dec 18, 2025 | |
| RADX Radiopharm Theranostics | Initiates: Buy | $18 | $4.97 | +262.17% | 1 | Jul 21, 2025 | |
| IBIO iBio, Inc. | Initiates: Buy | $3.6 | $2.42 | +48.76% | 1 | Jul 22, 2024 | |
| DARE Daré Bioscience | Upgrades: Buy | $36 | $1.69 | +2,030.18% | 2 | May 15, 2024 | |
| OTLK Outlook Therapeutics | Upgrades: Buy | $31 | $0.43 | +7,212.53% | 1 | Jan 25, 2024 | |
| LNTH Lantheus Holdings | Initiates: Buy | $100 | $64.89 | +54.11% | 1 | Nov 30, 2023 | |
| EDSA Edesa Biotech | Maintains: Buy | $57 | $1.12 | +4,989.29% | 2 | Oct 12, 2023 | |
| GNLX Genelux | Initiates: Hold | $25 | $2.39 | +946.03% | 1 | May 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $5.45 | +244.04% | 1 | Jan 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $8 | $0.77 | +940.45% | 1 | Oct 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5.65 | $0.59 | +857.63% | 1 | Feb 2, 2022 |
Lisata Therapeutics
Jan 21, 2026
Downgrades: Hold
Price Target: n/a
Current: $4.54
Upside: -
Rein Therapeutics
Jan 21, 2026
Downgrades: Hold
Price Target: n/a
Current: $1.14
Upside: -
Verrica Pharmaceuticals
Dec 18, 2025
Upgrades: Buy
Price Target: $17
Current: $6.91
Upside: +146.02%
Radiopharm Theranostics
Jul 21, 2025
Initiates: Buy
Price Target: $18
Current: $4.97
Upside: +262.17%
iBio, Inc.
Jul 22, 2024
Initiates: Buy
Price Target: $3.6
Current: $2.42
Upside: +48.76%
Daré Bioscience
May 15, 2024
Upgrades: Buy
Price Target: $36
Current: $1.69
Upside: +2,030.18%
Outlook Therapeutics
Jan 25, 2024
Upgrades: Buy
Price Target: $31
Current: $0.43
Upside: +7,212.53%
Lantheus Holdings
Nov 30, 2023
Initiates: Buy
Price Target: $100
Current: $64.89
Upside: +54.11%
Edesa Biotech
Oct 12, 2023
Maintains: Buy
Price Target: $57
Current: $1.12
Upside: +4,989.29%
Genelux
May 18, 2023
Initiates: Hold
Price Target: $25
Current: $2.39
Upside: +946.03%
Jan 13, 2023
Initiates: Buy
Price Target: $19
Current: $5.45
Upside: +244.04%
Oct 21, 2022
Assumes: Buy
Price Target: $8
Current: $0.77
Upside: +940.45%
Feb 2, 2022
Initiates: Buy
Price Target: $5.65
Current: $0.59
Upside: +857.63%